Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells

被引：58

作者：

Leal, Ana S. ^{[1
,2
,3
]}

Wang, Rui ^{[3
]}

Salvador, Jorge A. R. ^{[1
,2
]}

Jing, Yongkui ^{[3
]}

机构：

[1] Univ Coimbra, Quim Farmaceut Lab, Fac Farm, P-3000548 Coimbra, Portugal

[2] Univ Coimbra, CNC Ctr Neurociencias & Biol Celular, P-3000517 Coimbra, Portugal

[3] Mt Sinai Sch Med, Tisch Canc Inst, Div Hematol Oncol, New York, NY 10029 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2012年 / 20卷 / 19期

关键词：

Ursolic acid; Heterocyclic derivatives; Antiproliferative; p53; NOXA; OLEANOLIC ACID; INHIBITION; APOPTOSIS; PROLIFERATION; ACTIVATION; PATHWAY; GROWTH;

D O I：

10.1016/j.bmc.2012.08.010

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of new heterocyclic derivatives of ursolic acid 1 were synthesized and evaluated for their anti-proliferative activity against AsPC-1 pancreatic cancer cells. Compounds 24-32, with an alpha,beta unsaturated ketone in conjugation with an heterocyclic ring in ring A have improved antiproliferative activities. Compound 32 is the most active compound with an IC50 of 1.9 mu M which is sevenfold more active than ursolic acid 1. Compound 32 arrests cell cycle in G1 phase and induces apoptosis in AsPC-1 cells with upregulation of p53, p21(waf1) and NOXA protein levels. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：5774 / 5786

页数：13

共 50 条

[31] c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells
Eva Ceballos
M Dolores Delgado
Pilar Gutierrez
Carlos Richard
Daniel Müller
Martin Eilers
Mats Ehinger
Urban Gullberg
Javier León
Oncogene, 2000, 19 : 2194 - 2204
[32] Association of JNK1 with p21waf1 and p53: Modulation of JNK1 activity
Xue, Y
Ramaswamy, NT
Hong, XM
Pelling, JC
MOLECULAR CARCINOGENESIS, 2003, 36 (01) : 38 - 44
[33] Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis
Zhang, Ruitao
Shi, Huirong
Ren, Fang
Liu, Huina
Zhang, Minghui
Deng, Youxing
Li, Xia
ONCOLOGY REPORTS, 2015, 33 (03) : 1235 - 1242
[34] c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells
Ceballos, E
Delgado, MD
Gutierrez, P
Richard, C
Müller, D
Eilers, M
Ehinger, M
Gullberg, U
León, J
ONCOGENE, 2000, 19 (18) : 2194 - 2204
[35] Expression and alteration of p53 and p21waf1/cip1 influence the sensitivity of chemoradiation therapy for esophageal cancer
Shimoyama, S
Konishi, T
Kawahara, M
Aoki, F
Harada, N
Shimizu, S
Murakami, T
Kaminishi, M
HEPATO-GASTROENTEROLOGY, 1998, 45 (23) : 1497 - 1504
[36] Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance
Shih, Chuen-Ming
Chen, Kwunmin
Wang, Yu-Chieh
Lee, Pei-Jung
Wang, Yi-Ching
CANCER DETECTION AND PREVENTION, 2007, 31 (05): : 366 - 370
[37] Gambogic acid triggers DNA damage signaling that induces p53/p21Waf1/CIP1 activation through the ATR-Chk1 pathway
Rong, Jing-Jing
Hu, Rong
Song, Xiu-Ming
Ha, Jun
Lu, Na
Qi, Qi
Tao, Lei
You, Qi-Dong
Guo, Qing-Long
CANCER LETTERS, 2010, 296 (01) : 55 - 64
[38] Reduced expression of p53 and p21WAF1/CIP1 sensitizes human breast cancer cells to paclitaxel and its combination with 5-fluorouracil
Johnson, KR
Fan, WM
ANTICANCER RESEARCH, 2002, 22 (6A) : 3197 - 3204
[39] Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1
Rattanawong, Arkornnut
Payon, Vilawan
Limpanasittikul, Wacharee
Boonkrai, Chatikorn
Mutirangura, Apiwat
Wonganan, Piyanuch
ONCOLOGY REPORTS, 2018, 39 (01) : 227 - 238
[40] Association of aberrant p53 and p21WAF1 immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan
Chang, KW
Lin, SC
Kwan, PC
Wong, YK
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2000, 29 (02) : 56 - 62

← 1 2 3 4 5 →